Harpal Kumar

Masters in Chemical Engineering from the University of Cambridge

MBA as a Baker Scholar from Harvard Business School

worked briefly as a research scientist with the UK Atomic Energy Authority

worked for 4 years in the London office of McKinsey and Co, "advising pharmaceutical clients on strategic issues"

CEO of The Papworth Trust "pioneering rehabilitation and housing services for people with acquired and congenital disabilities"

founding CEO of Nexan Group, "a venture capital-backed medical device company, creating and marketing novel cardio-respiratory monitoring technologies to reduce premature mortality in patients with congestive heart failure"

joined Cancer Research Technology Limited (CRT)

became Chief Operating Officer of Cancer Research UK in July 2004

a Board Member of the National Cancer Research Institute and Chairman of the Gray Cancer Research Trust